News on Hepatitis continually updated from thousands of sources around the net.
4 hrs ago | Independent.ie
AROUND 80 women who were infected with the potentially lethal Hepatitis C virus, due to contaminated blood products, have died.
Trending on the Topix Network
5 hrs ago | Synapse
I began my nursing career at UCSF's Adult Transplant Unit on 9 Long. We care for patients either receiving or donating a kidney, liver or pancreas.
9 hrs ago | Contra Costa Times
A small group of workers and patients from the OASIS clinic march down International Blvd. in Oakland, Calif.
11 hrs ago | India Talkies
Patna, March 6: Doctors at the Patna Medical College and Hospital are allegedly refusing to treat hepatitis patients due to fears of infection, and have demanded insurance cover.
12 hrs ago | The Motley Fool
The results are impressive, but in an increasingly crowded space with promising advances coming out of Gilead ( Curing hepatitis C The data from AbbVie's trial shows that the company's three drug combination cured 99% of patients with genotype 1b hepatitis C. Genotype 1 is the most prevalent genotype here in the U.S., with the 1b variation ... (more)
16 hrs ago | Business Wire
New Mountain Finance Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2013 and Declares First Quarter 2014 Dividend of $0.34 per Share )--New Mountain Finance Corporation Announces Financial Results for the Quarter and Year Ended December 31, 2013 and Declares First Quarter 2014 Dividend of $0.34 per Share Merck's ... (more)
Doctors are calling a newly-approved drug a " revolution" in treating the most common blood-borne infection in the United States.
Merck , known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus NS3/4A protease inhibitor, and MK-8742, an ... (more)
Dirty needles are to blame for a rising trend in hepatitis C cases in southern St Louis County, that has officials calling the trend a "public health crisis."
Journal of Interferon & Cytokine Research , led by Co-Editors-in-Chief Ganes C. Sen, Ph.D., and Thomas A. Hamilton, Ph.D., Chairman, Department of Immunology, Cleveland Clinic Foundation, is an authoritative... New Rochelle, NY, March 5, 2014-Chronic hepatitis C virus infection can lead to serious diseases such as cirrhosis and cancer of the liver, ... (more)
Your liver works hard to protect your health. It's a rugged, strong organ. But certain things - like alcohol, drugs, viruses, and excess weight - can damage it.
After the close Tuesday, Michael Yee of RBC Capital Markets launched coverage at outperform with a price target of 35. His move came a day after Arrowhead received FDA permission to launch a phase 2a trial of hepatitis B drug ARC-520 , which Yee believes could eventually result in a multibillion-dollar product as well as further drugs derived from ... (more)
Medical officials fear the rise of heroin abuse in Minnesota is connected to an increase in hepatitis C. Some suspect dirty needles may be to blame.
Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA, reports the latest issue of the Alimentary Pharmacology & Therapeutics .
The hepatitis C protease inhibitor faldaprevir added to pegylated interferon and ribavirin cured hepatitis C in nearly three-quarters of people with genotype 1 hepatitis C virus and HIV co-infection in the STARTVerso4 trial, equaling response rates for people with hepatitis C alone, according to a report at the 21st Conference on Retroviruses and ... (more)
U.S. health insurers are seeking help from state health officials to foot the bill for a new generation of hepatitis C treatments that could cost the nation $200 billion or more in the next five years.
Interferon- and ribavirin-free treatment using sofosbuvir, ledipasvir, and a third drug for as little as 6 weeks can cure a majority of previously untreated people with genotype 1 hepatitis C, including those with traditional predictors of poor response, according to results from the SYNERGY trial presented at the 21st Conference on Retroviruses ... (more)